Articles tagged "Kidney/pancreas transplantation"

2022 American Transplant Congress
High Incidence of BKPyV DNAemia After Simultaneous Pancreas-Kidney Transplantation
I. Helanterä¹, J. Räihä¹, S. von Moos², I. Lautenschlager³, V. Sallinen¹, M. Lempinen¹, T. Schachtner²
¹Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland, ²University Hospital Zurich, Zurich, Switzerland, ³Department of Virology and Immunology, Helsinki University Hospital, Helsinki, Finland
*Purpose: Polyomavirus BK (BKPyV) commonly reactivates after kidney transplantation and causes significant morbidity and increased risk of graft loss. However, data on the burden of…
2022 American Transplant Congress
Portal-Endocrine and Gastric-Exocrine Drainage Technique in Pancreatic Transplantation
H. Shokouh-Amiri¹, M. S. Naseer², R. McMillan¹, D. Aultman¹, S. Tandukar¹, N. Singh¹, G. B. Zibari¹
¹John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, ²Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA
*Purpose: Diagnosis of rejection has continued to be problematic in pancreas transplantation (PT). In 2007, we innovated a new surgical technique for PT, portal-endocrine and…
2022 American Transplant Congress
Extended Duration of Rabbit Antithymocyte Globulin (rATG) Induction in Kidney and Kidney/Pancreas Transplant Recipients
D. Majmundar, A. Di Carlo, A. Diamond
Temple University Hospital, Philadelphia, PA
*Purpose: Many transplant centers have endorsed an expanded duration of rabbit antithymocyte globulin (rATG) in the outpatient setting through peripheral administration to help minimize cost.…
2022 American Transplant Congress
Temporary Donor Splenic Transplant (Splenopheresis) in Simultaneous Kidney Transplant Provides a Safe Immunologic Window in Sensitized Patients
P. Di Cocco¹, S. Gaitonde², M. Spaggiari³, A. M. Fratti³, S. Akshelyan³, A. Jorge¹, E. Benedetti³, I. Tzvetanov³
¹University of Illinios at Chicago, Chicago, IL, ²Department of Pathology, University of Illinois at Chicago, Chicago, IL, ³University of Illinois at Chicago, Chicago, IL
*Purpose: Deceased donor solid organ transplant in sensitized recipients with donor specific antibodies (DSA) and positive flow cytometry cross matches (FXM) are challenging due to…
2022 American Transplant Congress
Tuberculosis (TB) Treatment without Rifampin in Kidney (K) and Kidney-Pancreas (KP) Transplantation (Tx)
M. V. Radisic¹, N. Pujato¹, P. M. Bravo¹, R. Del Grosso², M. Hunter², S. Beltramino³, L. Cornet¹, R. Livia Franzini⁴, A. C. Dotta⁴, L. Leon⁴, J. Walther⁴, P. Uva⁵, G. Werber³, M. C. Rial⁴
¹Infectious Diseases, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, ²Internal Medicine, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, ³Critical Care, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, ⁴Kidney Transplantation, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina, ⁵Kidney Pancreas Transplantation, ITAC (Instituto de Trasplante y Alta Complejidad), Ciudad Autonoma de Buenos Aires, Argentina
*Purpose: TB is a diagnostic and therapeutic challenge in K/KP Tx. Pharmacokinetic interaction between rifampin (RFP) and mTOR /calcineurin inhibitors (CNI) led to use of…
2022 American Transplant Congress
Favorable Outcomes in Older Recipients Receiving Simultaneous Kidney Pancreas Transplantation
P. Budhiraja¹, H. Me¹, J. Ninan², S. Reddy², s. S. Misra¹, R. Heilman¹, H. Khamash¹, K. Reddy¹, C. Jadloweic¹, N. Katariya¹, H. Chakkera¹
¹Mayo Clinic, Phoenix, AZ, ²Mayo Clinic, Rochester, MN
*Purpose: Improved therapeutic advances in diabetes mellitus care have resulted in a higher number of older diabetics on dialysis. The majority of centers use an…
2022 American Transplant Congress
Progression of Peripheral Vascular Disease After Kidney/Pancreas Transplantation
R. J. Knight, E. A. Graviss, D. T. Nguyen, Y. Ye, S. G. Yi, C. S. Bavare, A. R. Sadhu, H. Podder, M. Hobeika, R. McMillan, A. O. Gaber
Houston Methodist Hospital, Houston, TX
*Purpose: It is unclear whether kidney/pancreas (KP) transplantation will prevent the progression of peripheral vascular disease in patients with IDDM and ESRD. We sought to…
2022 American Transplant Congress
Longitudinal Monitoring of Simultaneous Pancreas and Kidney Transplant and Pancreas After Kidney Recipients Using Donor-Derived Cell-Free DNA
N. M. Ali¹, J. Miles², Z. Stewart³
¹Transplant Institute, NYU Langone Health, New York, NY, ²CareDx, Brisbane, NY, ³Transplant Institute, NYU Langone Health, New York, NM
*Purpose: The utility of dd-cfDNA in patients undergoing pancreas transplantation has not been well studied. Pancreatic rejection remains a major clinical concern. Early identification of…
2022 American Transplant Congress
Recipient and Grafts Outcomes in Simultaneous Kidney and Pancreas Transplantation with Steroid Avoidance in the United States
A. Cerise¹, A. Dinesh², V. Humphreville², S. Jackson³, R. Kandaswamy², S. Riad⁴
¹Surgery, University of Minnesota, Minnesota, MN, ²Surgery, University of Minnesota, Minneapolis, MN, ³Analytics, MHealth-Fairview, Minneapolis, MN, ⁴Medicine, University of Minnesota, Eden Prairie, MN
*Purpose: Steroid avoidance in kidney transplantation has been proven non-inferior. Data on steroid avoidance in simultaneous pancreas-kidney (SPK) is scant.*Methods: We utilized the Scientific Registry…
2022 American Transplant Congress
Ultra-Short Duration Prophylaxis for Hepatitis C Donor Positive to Recipient Negative Simultaneous Kidney/Pancreas Transplants
G. Gupta, I. Yakubu, A. Khan, R. Sterling
Virginia Commonwealth University, Richmond, VA
*Purpose: Recent trials have successfully utilized a strategy of hepatitis C virus (HCV) D+ [Donor nucleic acid test (NAT) positive]/R- (Recipient NAT negative) kidney and/or…